HER2 inhibitor

0 marketed 2 in Phase 2 1 in Phase 1

This page covers all HER2 inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting HER2.

Targets

Phase 2 pipeline (2)

HKI-272 · Puma Biotechnology, Inc. · Oncology
HKI-272 is a small molecule inhibitor of the human epidermal growth factor receptor 2 (HER2) tyrosine kinase.
Breast cancer cohort · Centre Leon Berard · Oncology
This drug targets the HER2 protein to inhibit cancer cell growth.

Phase 1 pipeline (1)

ARRY-380, HER2 inhibitor; oral · Seagen Inc. · Oncology
HER2 inhibitor